The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licence Agreement with Schlumberger

25 Sep 2015 07:00

RNS Number : 1664A
Highlands Natural Resources PLC
25 September 2015
 

 

Highlands Natural Resources plc ('Highlands' or 'the Company')

Indicative Terms for a Licence Agreement with Schlumberger in respect to DT Ultravert

 

Highlands Natural Resources, the London listed oil and gas company, announces that it has signed indicative terms for a licence agreement with Schlumberger Technology Corporation ('Schlumberger'), a 100% owned subsidiary of Schlumberger Limited, the world's leading supplier of technology, integrated project management and information solutions to customers working in the oil and gas industry, in relation to Diversion Technologies, LLC's ('Diversion') proprietary "DT Ultravert" re-fracking technology. Highlands owns a 75% stake in Diversion's current patent applications both in the US and globally.

 

The indicative agreement provides that Schlumberger will evaluate DT Ultravert by assessing the data gained from five field trials within one year.

 

Highlands CEO Robert B. Price said, "Highlands will continue to work closely with Schlumberger and the engineers and geologists on our Advisory Board to perfect the DT Ultravert technology by designing fracs in several basins throughout the world. Trials will be undertaken to demonstrate its effectiveness, which will provide us with valuable data regarding its application.

 

"We believe that if successful, DT Ultravert could represent a major disruptive force in the market and generate significant future revenue for Highlands."

 

About Diversion and DT Ultravert

 

Diversion is a well stimulation technology company based in Denver, Colorado, USA. Diversion's pending patents involve a method for oilfield stimulation (fracking). Specifically, Diversion's diverter technology, for which its patents are pending, is called DT Ultravert. Diverters are used by the oil and gas industry as a method of enhancing conductivity during fracture treatment by diverting fluids to untreated portions of the reservoir. The oil and gas industry has been searching for a breakthrough in diverting technology and Diversion believes that DT Ultravert may be a solution.

 

Where old diversion technologies typically divert near the well bore, DT Ultravert penetrates into the reservoir and diverts from where oil and gas have already been produced. The DT Ultravert process injects gas into the depleted area of the reservoir and re-pressurises the area, forcing the refracture fluid to divert to under-depleted areas. It is anticipated that Nitrogen will be, at least initially, the most commonly utilised gas employed by the technology. By diverting the fluid to previously untouched portions of the reservoir, the Directors believe that the re-stimulation will be far more effective. The process utilises existing oilfield service equipment for easy deployment anywhere in the world. Unlike conventional diverters that likely leave behind damaging solids in the reservoir, DT Ultravert uses non-damaging gasses that will easily flow back when the well is put on production.

 

On 25 May 2015, Highlands entered into an agreement with Diversion to acquire a 75 per cent. interest the intellectual property associated with DT Ultravert, including in any revenues arising from the commercialisation of the patents and all future patents which may be developed relating to DT Utravert.

 

 

**ENDS**

 

For further information, please visit www.highlandsnr.com, or contact:

 

Robert Price

Highlands Natural Resources plc

 +1 (0) 918 361 7000

Nick Tulloch

Cenkos Securities plc

+44 (0) 131 220 9772

Neil McDonald

Cenkos Securities plc

+44 (0) 131 220 9771 /

+44 (0) 207 397 1953

Lottie Brocklehurst

St Brides Partners Ltd

+44 (0) 20 7236 1177

Elisabeth Cowell

St Brides Partners Ltd

+44 (0) 20 7236 1177

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDZLFLEKFXBBV
Date   Source Headline
16th Aug 20217:00 amRNSChange of Name
3rd Aug 20214:00 pmRNSNotice of Results
30th Jul 20213:30 pmRNSHolding(s) in Company
29th Jul 20217:00 amRNSBusiness Update
8th Jul 20212:05 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSBusiness Update
7th Jun 20214:40 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSIssue of Warrants
28th May 20215:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSUpdate on ‘Chill’ orders
4th May 20217:00 amRNSSubscription raises £6m, LDA financing cancelled
30th Apr 20215:00 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSTrading Update
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20217:00 amRNSNovel Food Application
31st Mar 20215:00 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSIssue of Shares
25th Mar 20217:00 amRNSExercise of Share Options
15th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20219:06 amRNSSecond Price Monitoring Extn
9th Mar 20219:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSFinancing Agreement with LDA Capital
8th Mar 20212:45 pmRNSHolding(s) in Company
2nd Mar 20213:00 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSUS Distribution Update
15th Feb 20217:00 amRNSProgress Update
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSInterim Results
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
8th Jan 20217:00 amRNSCommencement of trading on the OTCQX
31st Dec 20207:00 amRNSUpdate on Sale of DTU
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20202:05 pmRNSSecond Price Monitoring Extn
16th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20206:00 pmRNSHolding(s) in Company
10th Dec 20206:00 pmRNSHolding(s) in Company
9th Dec 202010:00 amRNSHolding(s) in Company
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
30th Nov 20205:00 pmRNSTotal Voting Rights
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.